Archive for July 2026
Quick Note #19: Redesigning Retigabine to Avoid Previous Side Effects
Excerpt A Kv7 channel-targeting drug called retigabine was pulled from the market years ago after it resulted in some skin discoloration. Since then, it has been reformulated as azetukalner to…
Read MoreCompassionate Use & Expanded Access: A Parent’s Guide
Compassionate Use & Expanded Access: A Parent’s Guide What Is Compassionate Use / Expanded Access? Compassionate Use (officially called Expanded Access by the FDA) is a pathway that allows people…
Read MoreQ2 Quick Note #18: Study Characterizes 30 Individuals With KCNQ2-Related Disorders
Excerpt Researchers reviewed medical records of 30 individuals with KCNQ2 variants, looking for patterns in their seizures, development, and genotypes. What It’s About Most people in this study had their…
Read More